128 related articles for article (PubMed ID: 11997668)
1. Functional inactivation by interleukin-1beta of glyceraldehyde-3-phosphate dehydrogenase in insulin-secreting cells.
Veluthakal R; Khan I; Tannous M; Kowluru A
Apoptosis; 2002 Jun; 7(3):241-6. PubMed ID: 11997668
[TBL] [Abstract][Full Text] [Related]
2. Nitric oxide-induced carbonylation of Bcl-2, GAPDH and ANT precedes apoptotic events in insulin-secreting RINm5F cells.
Cahuana GM; Tejedo JR; Jiménez J; Ramírez R; Sobrino F; Bedoya FJ
Exp Cell Res; 2004 Feb; 293(1):22-30. PubMed ID: 14729054
[TBL] [Abstract][Full Text] [Related]
3. Exogenous nitric oxide (NO) generation or IL-1 beta-induced intracellular NO production stimulates inhibitory auto-ADP-ribosylation of glyceraldehyde-3-phosphate dehydrogenase in RINm5F cells.
Dimmeler S; Ankarcrona M; Nicotera P; Brüne B
J Immunol; 1993 Apr; 150(7):2964-71. PubMed ID: 8454867
[TBL] [Abstract][Full Text] [Related]
4. Ciliary neurotrophic factor potentiates the beta-cell inhibitory effect of IL-1beta in rat pancreatic islets associated with increased nitric oxide synthesis and increased expression of inducible nitric oxide synthase.
Wadt KA; Larsen CM; Andersen HU; Nielsen K; Karlsen AE; Mandrup-Poulsen T
Diabetes; 1998 Oct; 47(10):1602-8. PubMed ID: 9753298
[TBL] [Abstract][Full Text] [Related]
5. gamma-tocopherol partially protects insulin-secreting cells against functional inhibition by nitric oxide.
Sjöholm A; Berggren PO; Cooney RV
Biochem Biophys Res Commun; 2000 Oct; 277(2):334-40. PubMed ID: 11032727
[TBL] [Abstract][Full Text] [Related]
6. Differential sensitivity to beta-cell secretagogues in cultured rat pancreatic islets exposed to human interleukin-1 beta.
Eizirik DL; Sandler S; Hallberg A; Bendtzen K; Sener A; Malaisse WJ
Endocrinology; 1989 Aug; 125(2):752-9. PubMed ID: 2666106
[TBL] [Abstract][Full Text] [Related]
7. Novel roles for palmitoylation of Ras in IL-1 beta-induced nitric oxide release and caspase 3 activation in insulin-secreting beta cells.
Chen HQ; Tannous M; Veluthakal R; Amin R; Kowluru A
Biochem Pharmacol; 2003 Nov; 66(9):1681-94. PubMed ID: 14563479
[TBL] [Abstract][Full Text] [Related]
8. Rat pancreatic islet and RINm5F cell responses to epiandrosterone, dehydroepiandrosterone and interleukin-1 beta.
Laychock SG
Biochem Pharmacol; 1998 May; 55(9):1453-64. PubMed ID: 10076538
[TBL] [Abstract][Full Text] [Related]
9. Dual functional effects of interleukin-1beta on purine nucleotides and insulin secretion in rat islets and INS-1 cells.
Meredith M; Rabaglia ME; Corbett JA; Metz SA
Diabetes; 1996 Dec; 45(12):1783-91. PubMed ID: 8922366
[TBL] [Abstract][Full Text] [Related]
10. The stimulatory effect of IL-1beta on the insulin secretion of rat pancreatic islet is not related with iNOS pathway.
Jeong IK; Oh SH; Chung JH; Min YK; Lee MS; Lee MK; Kim KW
Exp Mol Med; 2002 Mar; 34(1):12-7. PubMed ID: 11989973
[TBL] [Abstract][Full Text] [Related]
11. Transforming growth factor beta 1 prevents cytokine-mediated inhibitory effects and induction of nitric oxide synthase in the RINm5F insulin-containing beta-cell line.
Mabley JG; Cunningham JM; John N; Di Matteo MA; Green IC
J Endocrinol; 1997 Dec; 155(3):567-75. PubMed ID: 9488002
[TBL] [Abstract][Full Text] [Related]
12. Inhibitory effects of epicatechin on interleukin-1beta-induced inducible nitric oxide synthase expression in RINm5F cells and rat pancreatic islets by down-regulation of NF-kappaB activation.
Kim MJ; Ryu GR; Kang JH; Sim SS; Min DS; Rhie DJ; Yoon SH; Hahn SJ; Jeong IK; Hong KJ; Kim MS; Jo YH
Biochem Pharmacol; 2004 Nov; 68(9):1775-85. PubMed ID: 15450943
[TBL] [Abstract][Full Text] [Related]
13. Irreversible inhibition of metabolic function and islet destruction after a 36-hour exposure to interleukin-1beta.
Scarim AL; Heitmeier MR; Corbett JA
Endocrinology; 1997 Dec; 138(12):5301-7. PubMed ID: 9389514
[TBL] [Abstract][Full Text] [Related]
14. Suppression of interleukin-1 beta-induced nitric oxide production in RINm5F cells by inhibition of glucose-6-phosphate dehydrogenase.
Guo L; Zhang Z; Green K; Stanton RC
Biochemistry; 2002 Dec; 41(50):14726-33. PubMed ID: 12475221
[TBL] [Abstract][Full Text] [Related]
15. Interleukin-1beta regulates phospholipase D-1 expression in rat pancreatic beta-cells.
Chen MC; Paez-Espinosa V; Welsh N; Eizirik DL
Endocrinology; 2000 Aug; 141(8):2822-8. PubMed ID: 10919268
[TBL] [Abstract][Full Text] [Related]
16. IL-1beta-induced nitric oxide release from insulin-secreting beta-cells: further evidence for the involvement of GTP-binding proteins.
Tannous M; Veluthakal R; Amin R; Kowluru A
Diabetes Metab; 2002 Dec; 28(6 Pt 2):3S78-84; discussion 3S108-12. PubMed ID: 12688637
[TBL] [Abstract][Full Text] [Related]
17. Flavonoids protect against cytokine-induced pancreatic beta-cell damage through suppression of nuclear factor kappaB activation.
Kim EK; Kwon KB; Song MY; Han MJ; Lee JH; Lee YR; Lee JH; Ryu DG; Park BH; Park JW
Pancreas; 2007 Nov; 35(4):e1-9. PubMed ID: 18090225
[TBL] [Abstract][Full Text] [Related]
18. Suppressive effects of a selective inducible nitric oxide synthase (iNOS) inhibitor on pancreatic beta-cell dysfunction.
Kato Y; Miura Y; Yamamoto N; Ozaki N; Oiso Y
Diabetologia; 2003 Sep; 46(9):1228-33. PubMed ID: 12898012
[TBL] [Abstract][Full Text] [Related]
19. Reversibility of interleukin-1 beta-induced islet destruction and dysfunction by the inhibition of nitric oxide synthase.
Corbett JA; McDaniel ML
Biochem J; 1994 May; 299 ( Pt 3)(Pt 3):719-24. PubMed ID: 7514870
[TBL] [Abstract][Full Text] [Related]
20. Interleukin-13 counteracts suppression induced by interleukin-1beta of glucose metabolism but not of insulin secretion in rat pancreatic islets.
Sternesjö J; Sandler S
Autoimmunity; 1997; 26(3):153-9. PubMed ID: 9550283
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
